Oncology letters

Keyphrases

Publications

volume 27, number 1, 2023

Tasuku Matsuoka, Masakazu Yashiro
Current status and perspectives of genetic testing in gastrointestinal cancer (Review). Oncology letters 27 (1) (2023)
Jun Wang, Guoliang Yao, Beike Zhang, Zerui Zhao, Yonggang Fan
Interaction between miR‑206 and lncRNA MALAT1 in regulating viability and invasion in hepatocellular carcinoma. Oncology letters 27 (1) (2023)
Yoshiko Ishioka, Hisashi Tanaka, Tomonori Makiguchi, Syunsuke Fujishima, Yasuhito Nunomura, Hiroaki Sakamoto, Toshihiro Shiratori, Kageaki Taima, Sadatomo Tasaka
Predictors of efficacy of anamorelin in patients with non‑small cell lung cancer and cachexia: A retrospective study. Oncology letters 27 (1) (2023)
Sangik Noh, Ahrong Ham, Je Ryung Gil, Miji Lee, Taekyu Lim
Intrahepatic cholangiocarcinoma initially diagnosed as adenocarcinoma of unknown primary with hepatoduodenal ligament lymph node metastases: A case report. Oncology letters 27 (1) (2023)
Ping Tian, Jinglan Deng, Cailing Ma, Ainipa Miershali, Gulikezi Maimaitirexiati, Qi Yan, Yating Liu, Hatimihan Maimaiti, Yuting Li, Changhui Zhou, Jingqin Ren, Lu Ding, Rong Li
CBX7 is involved in the progression of cervical cancer through the ITGβ3/TGFβ1/AKT pathway. Oncology letters 27 (1) (2023)
Harumi Saeki, Yoshiya Horimoto, May Thinzar Hlaing, Yuan Men, Lu Rong, Yumiko Ishizuka, Toshitaka Uomori, Emiko Yoshida, Yasuhisa Terao, Atsushi Arakawa, Tsuyoshi Saito, Takashi Yao
Clinicopathological and molecular pathological characteristics in tamoxifen‑related endometrial cancer. Oncology letters 27 (1) (2023)
Charalampos Mavridis, Maria Venihaki, Eirini Dermitzaki, Michail Deiktakis, Georgios Liapakis, Charalampos Mamoulakis
mRNA expression of CRF family members in urothelial bladder cancer. Oncology letters 27 (1) (2023)
Feiyi Cao, Sijie Ding, Cuiping Gu, Yao Zhou, Wei Hong, Ying Jin
Efficacy and outcome analysis: Combination of Endostar and chemotherapy as a neoadjuvant treatment of stage IIIA/IIIB squamous cell lung cancer. Oncology letters 27 (1) (2023)
Ke Tian, Ying Deng, Zhipeng Li, Huaxin Zhou, Hui Yao
AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathway. Oncology letters 27 (1) (2023)
Kazutoshi Toriyama, Takashi Okuma, Shinji Abe, Hiroyuki Nakamura, Kazutetsu Aoshiba
In vitro anticancer effect of azithromycin targeting hypoxic lung cancer cells via the inhibition of mitophagy. Oncology letters 27 (1) (2023)
Maysa Alhawamdeh, Belal Almajali, Wafa Hourani, Hamid Ali Nagi Al-Jamal, Abdullah Saleh Al-Wajeeh, Nesrin Riad Mwafi, Yousef Al-Hajaya, Hanan Kamel M Saad, Diana Anderson, Mahmoud Odeh, Ibraheam A Tarawneh
Effect of IFN‑γ encapsulated liposomes on major signal transduction pathways in the lymphocytes of patients with lung cancer. Oncology letters 27 (1) (2023)
Ping-An Zou, Zheng-Xu Yang, Xi Wang, Zhi-Wei Tao
[Retracted] Upregulation of CENPF is linked to aggressive features of osteosarcoma. Oncology letters 27 (1) (2023)
Qinghua Shu, Nannan Zhang, Jianbo Han, Xiaopeng Yan, Bowen Sha, Liang Zhao, Yongxiang Yi, Yufeng Zhang
Novel predictive nomograms based on aspartate aminotransferase‑to‑platelet ratio index for hepatocellular carcinoma with post‑operative adjuvant transarterial chemoembolization. Oncology letters 27 (1) (2023)
Yujiro Kawata, Kenta Watanabe, Ryoji Tokiya, Yoshiyuki Miyaji, Akiko Shiotani, Kuniaki Katsui
Rectal ulcer associated with lenvatinib 15 years after definitive radiotherapy for prostate cancer: A case report. Oncology letters 27 (1) (2023)
José A López-Méndez, José L Ventura-Gallegos, Ignacio Camacho-Arroyo, Marcela Lizano, Alberto J Cabrera-Quintero, Sandra L Romero-Córdoba, Mariano Martínez-Vázquez, Nadia J Jacobo-Herrera, Alfonso León-Del-Río, Adrian A Paredes-Villa, Alejandro Zentella-Dehesa
The inhibitory effect of trastuzumab on BT474 triple‑positive breast cancer cell viability is reversed by the combination of progesterone and estradiol. Oncology letters 27 (1) (2023)
Huidong Yang, Cheng He, Yi Feng, Jie Jin
Exosome‑delivered miR‑486‑3p inhibits the progression of osteosarcoma via sponging CircKEAP1/MARCH1 axis components. Oncology letters 27 (1) (2023)
Yuntao Ding, Huizhi Wang, Wenyu Cao, Tianyu Cao, Han Jiang, Zhengyue Yu, Yujing Zhou, Min Xu
TTC22 as a potential prognostic marker and therapeutic target in pancreatic cancer: Insights into immune infiltration and epithelial‑mesenchymal transition. Oncology letters 27 (1) (2023)
Yunlian Zou, Jinli Wang, Jinping Zhang, Qiang Guo, Zhengji Song, Hui Tang
Prognostic value of PD‑L1 expression and CD68 macrophages in tumor nest of patients with primary gastric cancer. Oncology letters 27 (1) (2023)
Dan Su, Tianqi Zhang, Huimin Huang, Xiaoyu Su, Ying Li, Xiuyan Wei, Yingshi Zhang
Selection of breast cancer subtypes to improve benefits of intensive dose‑dense chemotherapy: A systematic meta‑analysis. Oncology letters 27 (1) (2023)
Dung V Tran, Xuan Quy Luu, Huong T T Tran, Seung-Kwon Myung
Dietary and supplementary vitamin C intake and the risk of lung cancer: A meta‑analysis of cohort studies. Oncology letters 27 (1) (2023)
Xin Wei, Jinliang Ni, Lin Yuan, Xueliang Li
Hematoporphyrin derivative photodynamic therapy induces apoptosis and suppresses the migration of human esophageal squamous cell carcinoma cells by regulating the PI3K/AKT/mTOR signaling pathway. Oncology letters 27 (1) (2023)
Zhulin Yan, Wei Zhang, Keyu Sun
TREM1 is involved in the mechanism between asthma and lung cancer by regulating the Toll‑like receptor signaling pathway. Oncology letters 27 (1) (2023)
Xiangtian Shi, Jiarui Yang, Meng Wang, Long Xia, Lei Zhang, Shan Qiao
Hsa_circ_0050900 affects ferroptosis in intrahepatic cholangiocarcinoma cells by targeting hsa‑miR-605‑3p to regulate SLC3A2. Oncology letters 27 (1) (2023)
Ling Han, Chaopan Zheng, Shihai Wu
[Retracted] Long non‑coding RNA NEAT1 promotes the malignancy of laryngeal squamous cell carcinoma by regulating the microRNA‑204‑5p/SEMA4B axis. Oncology letters 27 (1) (2023)

volume 26, number 6, 2023

Yixin Zhang, Siwen Liang, Yan Zhang, Minghui Liu, Kai Zhang
Identification of a novel endocytosis‑associated gene signature for prognostic prediction in lung adenocarcinoma. Oncology letters 26 (6) (2023)
Penggang Dong, Xuezhi Du, Ting Yang, Dandan Li, Yunyi Du, Yaqing Wei, Jinjin Sun
PEX13 is a potential immunotherapeutic indicator and prognostic biomarker for various tumors including PAAD. Oncology letters 26 (6) (2023)
Xia Chen, Yiwei Tan, An'an Gong
Coexistence of small gastrointestinal stromal tumor and pancreatic cancer: A case report and literature review. Oncology letters 26 (6) (2023)
Huixi Li, Yaoying Chen, Miao Zhang, Hong Zhang
Colorectal cancer metastasis to the thyroid: A case report and review of the literature. Oncology letters 26 (6) (2023)
Yimei Meng, Chaojin Hong, Sifu Yang, Zhiquan Qin, Liu Yang, Yumei Huang
Roles of USP9X in cellular functions and tumorigenesis (Review). Oncology letters 26 (6) (2023)
Mian Ma, Yuhui Gong, Xiaoyu Tang, Peng Deng, Jinhong Qian, Xiaolong Hu, Jiandong Wu, Zhiliang Ding
Solitary fibrous tumor in the saddle area treated with neuroendoscopic surgery and proton therapy: A case report and literature review. Oncology letters 26 (6) (2023)
Huan Wang, Zhenyan Wu, Guangqing Shi, Jing Zhou, Zhenliang Xiao
Enteral lorlatinib after immune hyperprogression as a treatment option for anaplastic lymphoma kinase‑positive non‑small cell lung cancer: A case report. Oncology letters 26 (6) (2023)
Yi Gan, Zhihao Liu, Zhiwei Tang, Xiaojing Yao, Bo Zeng, Haoshuai Zhu
Efficacy of neoadjuvant therapy for lung squamous cell carcinoma and lung adenocarcinoma: A retrospective comparative study. Oncology letters 26 (6) (2023)
Takashi Nakayama, Ryo Saito, Shinji Furuya, Katsutoshi Shoda, Suguru Maruyma, Koichi Takiguchi, Kensuke Shiraishi, Hidenori Akaike, Yoshihiko Kawaguchi, Hidetake Amemiya, Hiromichi Kawaida, Nagaharu Tsukiji, Toshiaki Shirai, Hideyuki Shinmori, Masami Yamamoto, Sachiyo Nomura, Tetsuya Tsukamoto, Katsue Suzuki-Inoue, Daisuke Ichikawa
Inhibition of cancer cell‑platelet adhesion as a promising therapeutic target for preventing peritoneal dissemination of gastric cancer. Oncology letters 26 (6) (2023)
Yiying Song, Haiting Liu, Qingqing Xian, Chengzhi Gui, Mingjie Xu, Yunying Zhou
Mechanistic insights into UHRF1‑mediated DNA methylation by structure‑based functional clarification of UHRF1 domains (Review). Oncology letters 26 (6) (2023)
Junning Liu, Shu Yan, Guangnian Zhang, Linfeng Yang, Song Wei, Pengsheng Yi
A retrospective study of transarterial chemoembolization (TACE) combined with lenvatinib compared with TACE monotherapy for BCLC B2 stage hepatocellular carcinoma. Oncology letters 26 (6) (2023)
Ninna Aggerholm-Pedersen, Thomas Baad-Hansen, Holger Jon Møller, Birgitte Sandfeld-Paulsen
Role of high‑sensitivity C‑reactive protein in patients with sarcoma. Oncology letters 26 (6) (2023)
Yi-Lin Chen, Chien-Chung Lin, Yu-Ting Yu, Wan-Li Chen, Shu-Ching Yang, Wenya Huang, Wu-Chou Su, Nan-Haw Chow, Chung-Liang Ho
Clinical implications of PNA‑sequencing as a complementary test for EGFR mutation analysis in human lung cancer. Oncology letters 26 (6) (2023)
Mei Kang, Liyang Zhu, Mingwei Yang, Yin Zhang, Shiyu Wang, Yichun Wang
Rare presentation of esophageal squamous cell carcinoma with rectal metastasis: A case report. Oncology letters 26 (6) (2023)
Yuhong Zheng, Jingfeng Zong, Yansong Chen, Junying Guo, Tianzhu Lu, Xiaoqin Xin, Yan Chen
Lack of association between XRCC1 SNPs and acute radiation‑induced injury or prognosis in patients with nasopharyngeal carcinoma. Oncology letters 26 (6) (2023)
Zixiong Li, Yanping Xu, Wenshu Qu, Ping Liu, Yan Zhu, Hui Li, Ying Guo, Xiufeng Liu
Efficacy and safety of hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and tyrosine kinase inhibitors in advanced hepatocellular carcinoma: A systematic review and meta‑analysis. Oncology letters 26 (6) (2023)
Fei Wu, Chengwei Xia, Rui Hai, Xiaodong Chen, Meirong Li, Qingxi Guo, Shanshan Liu, Xiangyu Zhou
Papillary thyroid carcinoma with clear cell renal cell carcinoma metastasized to the thyroid gland: A case report. Oncology letters 26 (6) (2023)
Dongjian Li, Zhiguo Sun, Ling Ma, Shaohua Liu
Recurrence of scalp angiosarcoma after multiple surgeries: A case report and literature review. Oncology letters 26 (6) (2023)
Lizhi Fan, Ying He, Yufeng Li, Xinxin Li, Dan Liu, Rui Wang
Efficacy and safety of traditional Chinese medicine nursing intervention in postoperative patients after gastrectomy. Oncology letters 26 (6) (2023)
Weipeng Liu, Zongrui Li, Xiaopeng Li, Haiyang Cao, He Jiang, Qingbin Niu, Baoguang Hu
Influence of tumor mycobiome on cancer pathogenesis (Review). Oncology letters 26 (6) (2023)
Site Yu, Wenjie Feng, Jizhang Zeng, Situo Zhou, Yinghua Peng, Pihong Zhang
GALNT12 promotes fibrosarcoma growth by accelerating YAP1 nuclear localization. Oncology letters 26 (6) (2023)
Jiang Chang, Chengyi Xin, Yong Wang, Ying Wang
Dihydroartemisinin inhibits liver cancer cell migration and invasion by reducing ATP synthase production through CaMKK2/NCLX. Oncology letters 26 (6) (2023)
Masamitsu Takahashi, Takuya Araki, Hideaki Yashima, Ayumu Nagamine, Daisuke Nagano, Koujirou Yamamoto
Increased c‑SRC expression is involved in acquired resistance to lenvatinib in hepatocellular carcinoma. Oncology letters 26 (6) (2023)
Mahmoud Abbas, Barbara Heitplatz, Christof Bernemann, Martin Boegemann, Marcel Trautmann, Andres Jan Schrader, Eva Wardelmann, Katrin Schlack
Immunohistochemical expression of TROP‑2 (TACSTD2) on the urothelial carcinoma of the urinary bladder and other types of cancer. Oncology letters 26 (6) (2023)
Yumiko Koi, Yuki Yamamoto, Saori Fukunaga, Keiko Kajitani, Masahiro Ohara, Yutaka Daimaru, Hidetoshi Tahara, Ryuichiro Tamada
Assessment of the expression of microRNAs‑221‑3p, ‑146a‑5p, ‑16‑5p and BCL2 in oncocytic carcinoma of the breast: A case report. Oncology letters 26 (6) (2023)
Yidong Ge, Xiaoqi Ni, Jingyun Li, Meng Ye, Xiaofeng Jin
Roles of estrogen receptor α in endometrial carcinoma (Review). Oncology letters 26 (6) (2023)